Clinical Trial Update: A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA) [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled trial evaluating STS01 for mild-to-moderate alopecia areata has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• STS01

Snippet

Sponsor: Soterios Ltd | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED